Quantcast

Januvia Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information About Potential Januvia Side Effects, Including Januvia Pancreatic Cancer

July 3, 2013

The Firm is currently investigating Januvia Lawsuits Involving Alleged Cases of Januvia Pancreatic Cancer, Januvia Pancreatitis, and Januvia Thyroid Cancer.

New York, New York (PRWEB) July 03, 2013

A new Januvia lawsuit website has been launched by Bernstein Liebhard LLP to provide information to individuals who may be concerned about potential Januvia side effects, including Januvia pancreatic cancer, Januvia pancreatitis and Januvia thyroid cancer. The website will also be updated regularly with the most current information regarding the growing litigation surrounding the type 2 diabetes drug and its alleged association with pancreatic cancer, pancreatitis, and thyroid cancer.

“Januvia and similar type 2 diabetes drugs are coming under increased scrutiny amid concerns that they may increase the risk that a patient will develop pancreatic cancer, pancreatitis or thyroid cancer. This website will provide valuable information to worried patients and their families regarding the potential risks associated with Januvia, as well as their options for legal recourse,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Januvia lawsuit consultations to anyone who may have been harmed after taking Januvia or a similar drug.

Januvia Lawsuits

Januvia belongs to a class of type2 diabetes drugs known as incretin mimetics, which help regulate blood sugar by stimulating insulin production by the pancreas. The U.S. Food & Drug Administration (FDA) announced in March that it was investigating incretin mimetics after results from an unpublished study indicated these medications might cause pre-cancerous changes in the pancreas.* Most recently, a report published June 10th in the British Medical Journal revealed previously unpublished data that indicated the manufacturers of incretin mimetics may have downplayed the drugs’ potential to harm the pancreas.**

In 2009, a caution regarding a potential Januvia pancreatitis risk was added to the drug’s label after the FDA became aware of 88 post-marketing cases of acute pancreatitis in patients taking Januvia.*** In 2011, a study published in Gastroenterology found that use of Januvia appeared to increase the risk of pancreatitis and pancreatic cancer, while two cases of thyroid cancer were also reported in the patients who took Januvia.****

Court documents indicate that Merck & Co. has been named in a number of lawsuits filed on behalf of patients who allegedly developed Januvia pancreatic cancer, Januvia pancreatitis, or Januvia thyroid cancer. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments on July 25, 2013, regarding the proposed establishment of a multidistrict litigation for all federally-filed claims involving incretin mimetics, Including Januvia lawsuits. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, JPML)

Patients who have allegedly developed Januvia pancreatic cancer, thyroid cancer or pancreatitis may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about filing a Januvia lawsuit, please visit Bernstein Liebhard LLP’s website. For more information, please call 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm343187.htm

**bmj.com/open-data/incretin#alternate; BMJ, June 10, 2013

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm; September 25, 2009

***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info (at) consumerinjurylawyers (dot) com

http://www.januvialawsuit2013.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/januvia-lawsuit/januvia-pancreatic-cancer/prweb10899936.htm


Source: prweb



comments powered by Disqus